These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36536644)
21. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193 [TBL] [Abstract][Full Text] [Related]
22. Circulating CD4+ CD25 high FoxP3+ T cells vary in different clinical forms of leprosy. Attia EA; Abdallah M; Saad AA; Afifi A; El Tabbakh A; El-Shennawy D; Ali HB Int J Dermatol; 2010 Oct; 49(10):1152-8. PubMed ID: 20883403 [TBL] [Abstract][Full Text] [Related]
23. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369 [TBL] [Abstract][Full Text] [Related]
24. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy. Sasiain MD; de la Barrera S; Valdez R; Balina LM Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841 [TBL] [Abstract][Full Text] [Related]
26. T regulatory cells and plasmocytoid dentritic cells in hansen disease: a new insight into pathogenesis? Massone C; Nunzi E; Ribeiro-Rodrigues R; Talhari C; Talhari S; Schettini APM; Parente JNT; Brunasso AM; Puntoni M; Clapasson A; Noto S; Cerroni L Am J Dermatopathol; 2010 May; 32(3):251-256. PubMed ID: 20075708 [TBL] [Abstract][Full Text] [Related]
27. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions. Santos MB; de Oliveira DT; Cazzaniga RA; Varjão CS; Dos Santos PL; Santos MLB; Correia CB; Faria DR; Simon MDV; Silva JS; Dutra WO; Reed SG; Duthie MS; de Almeida RP; de Jesus AR Scand J Immunol; 2017 Jul; 86(1):40-49. PubMed ID: 28426172 [TBL] [Abstract][Full Text] [Related]
28. Nodular leprosy of childhood and tuberculoid leprosy: a comparative, morphologic, immunopathologic and quantitative study of skin tissue reaction. Fakhouri R; Sotto MN; Manini MI; Margarido LC Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):218-26. PubMed ID: 14608817 [TBL] [Abstract][Full Text] [Related]
29. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy. Singh I; Yadav AR; Mohanty KK; Katoch K; Bisht D; Sharma P; Sharma B; Gupta UD; Sengupta U Cell Immunol; 2012; 278(1-2):63-75. PubMed ID: 23121977 [TBL] [Abstract][Full Text] [Related]
30. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366 [TBL] [Abstract][Full Text] [Related]
31. Expression of cyclooxygenase type 2 in lepromatous and tuberculoid leprosy lesions. Kiszewski AE; Becerril E; Baquera J; Ruiz-Maldonado R; Hernández Pando R Br J Dermatol; 2003 Apr; 148(4):795-8. PubMed ID: 12752141 [TBL] [Abstract][Full Text] [Related]
32. An analysis of in vitro T cell responsiveness in lepromatous leprosy. Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804 [TBL] [Abstract][Full Text] [Related]
33. Th9 cytokines response and its possible implications in the immunopathogenesis of leprosy. de Sousa JR; Pagliari C; de Almeida DSM; Barros LFL; Carneiro FRO; Dias LB; de Souza Aarão TL; Quaresma JAS J Clin Pathol; 2017 Jun; 70(6):521-527. PubMed ID: 27927694 [TBL] [Abstract][Full Text] [Related]
34. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. Kim J; Uyemura K; Van Dyke MK; Legaspi AJ; Rea TH; Shuai K; Modlin RL J Immunol; 2001 Jul; 167(2):779-86. PubMed ID: 11441083 [TBL] [Abstract][Full Text] [Related]
35. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells. Mitra DK; Rajalingam R; Taneja V; Bhattacharyya BC; Mehra NK Clin Immunol Immunopathol; 1997 Jan; 82(1):60-7. PubMed ID: 9000043 [TBL] [Abstract][Full Text] [Related]
36. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients. Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125 [TBL] [Abstract][Full Text] [Related]
37. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435 [TBL] [Abstract][Full Text] [Related]
38. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients. Choi IH; Shin JS; Kim JD; Kim SJ Yonsei Med J; 1991 Sep; 32(3):237-42. PubMed ID: 1781183 [TBL] [Abstract][Full Text] [Related]
39. Study of serum zinc level in leprosy. Saxena N; Sharma RP; Singh VS Indian J Lepr; 1988 Oct; 60(4):556-61. PubMed ID: 3253334 [TBL] [Abstract][Full Text] [Related]
40. A hypothetical role for Notch signaling pathway in immunopathogenesis of leprosy. Serrano-Coll H; Acevedo-Saenz L; Cardona-Castro N Med Hypotheses; 2017 Nov; 109():162-169. PubMed ID: 29150278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]